Wu X - Search Results

1

Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.

Li D, Xu S, Cai H, Pei L, Wang L, Wu X, Yao H, Jiang J, Sun Y, Xu J. Li D, et al. Among authors: wu x. ChemMedChem. 2013 May;8(5):812-8. doi: 10.1002/cmdc.201200559. Epub 2013 Mar 20. ChemMedChem. 2013. PMID: 23520191

2

Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.

Li D, Cai H, Jiang B, Liu G, Wang Y, Wang L, Yao H, Wu X, Sun Y, Xu J. Li D, et al. Among authors: wu x. Eur J Med Chem. 2013 Jan;59:322-8. doi: 10.1016/j.ejmech.2012.11.002. Epub 2012 Nov 21. Eur J Med Chem. 2013. PMID: 23274570

3

Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.

Li D, Xu S, Cai H, Pei L, Zhang H, Wang L, Yao H, Wu X, Jiang J, Sun Y, Xu J. Li D, et al. Among authors: wu x. Eur J Med Chem. 2013 Jun;64:215-21. doi: 10.1016/j.ejmech.2013.04.012. Epub 2013 Apr 11. Eur J Med Chem. 2013. PMID: 23644204

4

Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives.

Xu S, Li D, Pei L, Yao H, Wang C, Cai H, Yao H, Wu X, Xu J. Xu S, et al. Among authors: wu x. Bioorg Med Chem Lett. 2014 Jul 1;24(13):2811-4. doi: 10.1016/j.bmcl.2014.04.119. Epub 2014 May 9. Bioorg Med Chem Lett. 2014. PMID: 24835198

5

Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives.

Xu S, Pei L, Li D, Yao H, Cai H, Yao H, Wu X, Xu J. Xu S, et al. Among authors: wu x. Fitoterapia. 2014 Dec;99:300-6. doi: 10.1016/j.fitote.2014.10.005. Epub 2014 Oct 12. Fitoterapia. 2014. PMID: 25316557

6

Synthesis and Biological Evaluation of Oxygen-containing Heterocyclic Ring-fused 23-Hydroxybetulinic Acid Derivatives as Antitumor Agents.

Zhang H, Li F, Zhu P, Liu J, Yao H, Jiang J, Ye W, Wu X, Xu J. Zhang H, et al. Among authors: wu x. Chem Biol Drug Des. 2015 Oct;86(4):424-31. doi: 10.1111/cbdd.12543. Epub 2015 Mar 6. Chem Biol Drug Des. 2015. PMID: 25688519

7

Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.

Cai H, Huang X, Xu S, Shen H, Zhang P, Huang Y, Jiang J, Sun Y, Jiang B, Wu X, Yao H, Xu J. Cai H, et al. Among authors: wu x. Eur J Med Chem. 2016 Jan 27;108:89-103. doi: 10.1016/j.ejmech.2015.11.013. Epub 2015 Nov 11. Eur J Med Chem. 2016. PMID: 26638042

8

Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria.

Xu S, Luo S, Yao H, Cai H, Miao X, Wu F, Yang DH, Wu X, Xie W, Yao H, Chen ZS, Xu J. Xu S, et al. Among authors: wu x, wu f. J Med Chem. 2016 May 26;59(10):5022-34. doi: 10.1021/acs.jmedchem.6b00408. Epub 2016 Apr 27. J Med Chem. 2016. PMID: 27089099

9

Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.

Bi Y, Xu J, Wu X, Ye W, Yuan S, Zhang L. Bi Y, et al. Among authors: wu x. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1475-8. doi: 10.1016/j.bmcl.2006.09.096. Epub 2006 Oct 4. Bioorg Med Chem Lett. 2007. PMID: 17275295

10

Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates.

Xu J, Yang J, Ran Q, Wang L, Liu J, Wang Z, Wu X, Hua W, Yuan S, Zhang L, Shen M, Ding Y. Xu J, et al. Among authors: wu x. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4741-4. doi: 10.1016/j.bmcl.2008.06.097. Epub 2008 Jul 3. Bioorg Med Chem Lett. 2008. PMID: 18644718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,428 results

Search Page

Filters